Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07425717Not ApplicableNot Yet Recruiting

Multicenter Study of Transcranial Magnetic Stimulation on Vision Restoration

Role: lead

NCT06616506Recruiting

Artificial Intelligence for Highly Myopic Cataract

Role: lead

NCT06600932Not ApplicableNot Yet Recruiting

Evaluation of TMS Visual Outcome

Role: lead

NCT03062085Recruiting

Shanghai High Myopia Study

Role: lead

All 4 trials loaded